Screening and management of gestational diabetes

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 29, Issue 3, 2015, Pages 339-349

  Benhalima, Katrien ^a   Devlieger, Roland ^a   Van Assché, Andre ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Gestational diabetes; Management; Overt diabetes; Screening

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; METFORMIN;

ARTICLE; FEMALE; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; HUMAN; LIFESTYLE MODIFICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUERPERIUM; SCREENING TEST; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIABETIC DIET; DISEASE MANAGEMENT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; KINESIOTHERAPY; METABOLISM; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL DIAGNOSIS; PROCEDURES;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIET, DIABETIC; DISEASE MANAGEMENT; EXERCISE THERAPY; FEMALE; GLUCOSE TOLERANCE TEST; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL DIAGNOSIS;

EID: 84933526273     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2014.07.026     Document Type: Article

References (81)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32(Suppl. 1):S62-7.
2. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008 358 1991-2002.
3. Gilmartin AB, Ural SH, Repke JT. Gestational diabetes mellitus. Rev Obstet Gynecol 2008 1 129-34.
4. Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and metae analysis. Lancet 2009 373 1773-9.
5. Gundersen EP, Chiang V, Pletscher MJ, et al. History of gestational diabetes mellitus and future risk of atherosclerosis in midelife: the Coronary Artery Risk Development in Young Adults study. J Am Heart Assoc 2014;3:e000490.
6. Nehring I, Chmitorz A, Reulen H, et al. Gestational diabetes predicts the risk of childhood overweight and abdominal circumference independent of maternal obesity. Diabet Med 2013 30 1449-56.
7. Kelstrup L, Damm P, Mathiesen ER, et al. Insulin resistance and impaired pancreatic betaecell function in adult offspring of women with diabetes in pregnancy. JCEM 2013 98 3793-801.
8. Kim SY, England JL, Sharma JA, et al. Gestational diabetes mellitus and risk of childhood overweight and obesity in offspring: a systematic review. Exp Diabetes Res 2011 2011 541308.
9. West NA, Kechris K, Dabelea D. Exposure to maternal diabetes in utero and DNA methylation patterns in the offspring. Immunometabolism 2013 1 1-9.
10. Ruchat SM, Houde AA, Voisin G, et al. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics 2013 8 935-43.
11. Vrachnis N, Antonakopoulos N, Iliodromiti Z, et al. Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring. Exp Diabetes Res 2012;2012. 538474, http://dx.doi.org/10.1155/2012/538474.
12. Claesson R, Aberg A, Marsal K. Abnormal fetal growth is associated with gestational diabetes mellitus later in life: populationebased register study. Acta Obstet Gynecol Scand 2007 86 652-6.
13. Jiwani A, Marseille E, Lohse N, et al. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 2012 25 600-10.
14. Buckley BS, Harreiter J, Damm P, et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 2012 29 844-54.
15. O'Sullivan JB, Mahan CM. Criteria for oral glucose tolerance test in pregnancy. Diabetes 1964 13 278-85.
16. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshope Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(Suppl. 2):S251-60.
17. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnostic and classification of hyperglycemia in pregnancy. Diabetes Care 2010 33 676-82.
18. Jenum AK, Møórkrid K, Sletner L, et al. Impact of ethnicity on gestational diabetes identified with the WHO and the modified IADPSG criteria: a populationebased cohort study. Eur J Endocrinol 2012 166 317-24.
19. Liao S, Mei J, Song W, et al. The impact of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) fasting glucose criterion on the prevalence and outcomes of gestational diabetes mellitus in Han Chinese women. Diabet Med 2014 31 341-51.
20. Ryan EA. Diagnosing gestational diabetes. Diabetologia 2011 54 480-6.
21. Waugh N, Pearson D, Royle P. Screening for hyperglycaemia in pregnancy: consensus and controversy. Best Pract Res Clin Endocrinol Metab 2010 24 553-71.
22. Cundy T, Ackermann E, Ryan EA. Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ 2014, 11;348:g1567. http://dx.doi.org/10.1136/bmj.g1567.
23. Committee on Obstetric Practice Screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 2011 118 751-3.
24. Vandorsten JP, Dodson WC, Espeland MA, et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consensus State Sci Statements 2013 29 1-31.
25. The World Health Organization guideline. Diagnostic criteria and classificationofhyperglycaemiafirstdetectedinpregnancy. 2013. http://apps.who.int/iris/bitstream/10665/85975/1/WHO-NMH-MND-13.2-eng.pdf [accessed on 17.11.13].
26. Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. JCEM 2013;98 4227-49.
27. American Diabetes Association. Standards of medical care in diabetese2014. Diabetes Care 2014;37:S14-80.
28. Lawrence JM, Contreras R, Chen W, et al. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008 31 899-904.
29. Preventive Services Task Force. Screening for gestational diabetes mellitus: U. S Preventive Services Rask Force recommendation statement. Ann Intern Med 2014 160 414-20.
30. Zhu WeW, Yang HeX, Wei YeM, et al. Evaluation of the value of fasting plasma glucose in first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 2013 36 586-90.
31. van Leeuwen M, Louwerse MD, Opmeer BC, et al. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG 2012 119 393-401.
32. Poomala GK, Rangaswamy V. A comparison of fasting plasma glucose and glucose challenge test for screening of gestational diabetes mellitus. J Obstet Gynaecol 2013 33 447-50.
33. Goldberg RJ, Ye C, Sermer M, et al. Circadian variation in the response to the glucose challenge test in pregnancy. Diabetes Care 2012 35 1578-84.
34. Fong A, Serra AE, Gabby L, et al. Use of hemoglobin A1c as an early predictor of gestational diabetes. Am J Obstet Gynecol 2014; (14): 00577-8. pii:S0002-93789.
35. Raiput R, Yadav Y, Raiput M, et al. Utility of Hba1c for diagnosis of gestational diabetes mellitus. Diabetes Res Clin Pract 2012 98 104-7.
36. Rowan JA, Budeen A, Sadler LC. Women with a nondiagnostic 75g glucose tolerance test but elevated HbA1c in pregnancy: an additional group of women with gestational diabetes. ANZJOG 2014 54 177-80.
37. Lowe P, Metzger BE, Dyer AR, et al. Hyperglycaemia and adverse pregnancy outcome (HAPO) study. Diabetes Care 2012 35 574-80.
38. Cosson E, Benbara A, Pharisien I, et al. Diagnostic and prognostic performances over 9 years of a selective screening strategy for gestational diabetes mellitus in a cohort of 18, 775 subjects. Diabetes Care 2013 36 598-603.
39. Cosson E, Cussace Pillegand C, Benbara A, et al. The diagnostic and prognostic performance of a selective screening strategy for gestational diabetes mellitus according to ethnicity in Europe. JCEM 2014 99 996-10 05.
40. Avalos GE, Owens LA, Dunne F. Applying current screening tools for gestational diabetes mellitus to a European population: Is it time to change? Diabetes Care 2013 36 3040-4.
41. Göbl CS, Bozkurt L, Rivic, et al. A twoestep screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus. Diabetologia 2012 55 3173-81.
42. Savonae Ventura C, Vassallo J, Marre M, et al., for the MGSDeGDM study group. A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women. Int J Gynecol Obstet 2013 120 240-4.
43. U. S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U. S Preventive Services Rask Force recommendation statement. Ann Intern Med 2008 148 759-65.
44. Donovan L, Hartling L, Muise M, et al. Screening tests for gestational diabetes: a systematic review for the U. S. Preventive Services Task Force. Ann Intern Med 2013 159 115-22.
45. Prutsky GJ, Domecq JP, Sundaresh V, et al. Screening for gestational diabetes: a systematic review and metaeanalysis. JCEM 2013 98 4311-8.
46. Benhalima K, Hanssens M, Devlieger R, et al. Analysis of pregnancy outcomes using the new IADPSG recommendation compared with the Carpenter and Coustan criteria in an area with a low prevalence of gestational diabetes. Int J Endocrinology 2013. http://dx.doi.org/10.1155/2013/248.121.
47. Hirst JE, Tran TS, Do MA, et al. Consequences of gestational diabetes in an urban hospital in Viet Nam: a prospective cohort study. Plos Med 2012;9(7):e1001272. http://dx.doi.org/10.1371/journal.pmed.1001272.
48. Reyese Munîez E, Parra A, Castilloe Mora A, et al. Effect of the International Association of Diabetes and Pregnancy Study Groups diagnostic criteria on the prevalence of gestational diabetes in urban Mexican women: a crossesectional study. Endocr Pract 2012 18 146-51.
49. Bodmere Roy S, Morin L, Cousineau J, et al. Pregnancy outcomes in women with and without diabetes mellitus according to the international association of the diabetes in pregnancy study groups criteria. Obstet Gynecol 2012 120 746-52.
50. Kaltere Leibovici O, Freedman LS, Olmer L, et al. Screening and diagnosis of gestational diabetes mellitus. Critical appraisal of the new International Association of Diabetes in Pregnancy Study Group recommendations on a national level. Diabetes Care 2012 35 1894-6.
51. Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomesea systematic review of the World Health Organization (WHO) and the new International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy and Childbirth 2012 12 23 1-13.
52. Hartling L, Dryden DM, Guthrie A, et al. Diagnostic thresholds for gestational diabetes and their impact on pregnancy outcomes: a systematic review. Diabet Med 2014 31 319-31.
53. Colagiuri S, Falavigna M, Agarwal MM, et al. Strategies for implementing the WHO diagnostic criteria and classification of hyperglycemia first detected in pregnancy. Diabetes Res Clin Pract 2014 103 364-72.
54. Werner EF, Petther CM, Zuckerwise L, et al. Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of Diabetes and Pregnancy Study Groups costeeffective? Diabetes Care 2012 35 529-35.
55. Mission JF, Ohno MS, Cheng YW, et al. Gestational diabetes screening with new IADPSG guidelines: a costeeffectiveness analysis. Am J Obstet Gynecol 2012 207 326 e1-9.
56. Gillespie P, Culligan J, O'Neill C, et al. Modeling the independent effects of gestational diabetes mellitus on maternity care and costs. Diabetes Care 2013 36 1111-6.
57. Agarwal MM, Dhatt GS, Othman Y. Gestational diabetes in a tertiary care hospital: implications of applying the IADPSG criteria. Arch Gynecol Obstet 2012 286 373-8.
58. Noctor E, Crowe C, Carmody LA, et al. ATLANTIC DIP: simplifying the followeup of women with previous gestational diabetes. Eur J Endocrinol 2013 169 681-7.
59. Picón MJ, Murri M, Munoz A, et al. Hemoglobin A1c versus oral glucose tolerance test in postpartum diabetes screening. Diabetes Care 2012 35 1648-53.
60. Diabetes Prevention Program Research Group. Reduction in the incidence of type, 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 346 393-403.
61. Crowther CA, Hiller JE, Moss JR, et al., Australian Carbohydrate Intolerance study in Pregnancy Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005 352 2477-86.
62. Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009 361 1339-48.
63. Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and metaeanalysis for the U. S. Preventive Services Task Force and the National Institutes of health office of medical applications of research. Ann Intern Med 2013 159 123-9.
64. Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight gain during pregnancy: reexamining the guidelines. In: Rasmussen KM, Yaktine AL, editors. The National Academies Collection: reports funded by National Institutes of Health. Washington (DC): The National Academies Press; 2009.
65. Prutsky GJ, Domecq JP, Wang Z, et al. Glucose targets in pregnant women with diabetes: a systematic review and metaanalysis. JCEM 2013 98 4319-24.
66. Mathiesen ER, Hod M, Ivanisevic M, et al. Maternal efficacy and safety outcomes i a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012 35 2012-7.
67. Price N, Bartlett C, Gillmer M. Use of insulin glargine during pregnancy: a caseecontrol pilot study. BJOG 2007 114 453-7.
68. Durnwald CP, Landon MB. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med 2008 21 309-13.
69. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a metaeanalysis. Plos One 2013;8:e64585.
70. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008 358 2003-15.
71. Zeng YC, Li MJ, Chen Y, et al. The use of glyburide in the management of gestational diabetes mellitus: a metaeanalysis. Adv Med Sci 2014 59 95-101.
72. Committee on Practice BulletinseObstetrics. The American College of Obstetrics and Gynecologists. Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynecol 2013 122 406-16.
73. Coustan DR. Gestational diabetes mellitus. Clin Chem 2013 59 1310-21.
74. ACOG committee on Practice Bulletinse Obstetrics. Gestational diabetes. Obstet Gynecol 2001 98 525-38.
75. Van Assche FA, Gepts W. The cytological composition of the foetal endocrine pancreas in normal and pathological conditions. Diabetologia 1971 50 2279-86.
76. Galjaard S, Devlieger R, Van Assche FA. Fetal growth and developmental programming. J Perinat Med 2013 41 101-5.
77. Van Assche FA. Symmetric and asymmetric macrosomia. Am J Obstet Gynecol 1997 177 1563-4.
78. O'Connor C, Doolan A, O'Higgins A, et al. Fetal subcutaneous tissue measurements in pregnancy as a predictor of neonatal total body composition. Prenat Diagn 2014 34 952-5.
79. Maso G, Piccoli M, Parolin S, et al. Diabetes in pregnancy: timing and mode of delivery. Curr Diab Rep 2014 14 506.
80. ACOG Committee on Practice Bulletins. Gestational diabetes 2013 mellitus. Obstet Gynecol 2013 122 406-16.
81. Royal College of Obstetricians and Gynaecologists. Shoulder dystocia. Greene Top Guideline No. 42. London: RCOG Press; 2012.